255 related articles for article (PubMed ID: 9075230)
1. New insights into therapy with monoclonal antibodies in allograft transplantation.
Schena FP
Nephrol Dial Transplant; 1997; 12 Suppl 1():55-8. PubMed ID: 9075230
[No Abstract] [Full Text] [Related]
2. Review and preview of anti-T-cell antibodies.
Helderman JH
Transplant Proc; 1995 Oct; 27(5 Suppl 1):8-9. PubMed ID: 7482824
[No Abstract] [Full Text] [Related]
3. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection.
Lazarovits AI; Rochon J; Banks L; Hollomby DJ; Muirhead N; Jevnikar AM; White MJ; Amlot PL; Beauregard-Zollinger L; Stiller CR
Transplant Proc; 1993 Feb; 25(1 Pt 1):820-2. PubMed ID: 7679844
[No Abstract] [Full Text] [Related]
4. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.
Alausa M; Almagro U; Siddiqi N; Zuiderweg R; Medipalli R; Hariharan S
Clin Transplant; 2005 Feb; 19(1):137-40. PubMed ID: 15659147
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies in organ transplantation.
Valdés RH
Transplant Proc; 1996 Dec; 28(6):3293. PubMed ID: 8962277
[No Abstract] [Full Text] [Related]
6. The clinical application of monoclonal antibody therapies in renal transplantation.
Dhanireddy KK; Xu H; Mannon RB; Hale DA; Kirk AD
Expert Opin Emerg Drugs; 2004 May; 9(1):23-37. PubMed ID: 15155134
[TBL] [Abstract][Full Text] [Related]
7. CD4 monoclonal antibodies in the preclinical dog renal allograft model.
Watson CJ; Davies HS; Metcalfe SM; Cobbold SP; Rebello PR; Collier DS; Waldmann H; Calne RY
Transplant Proc; 1993 Feb; 25(1 Pt 1):804-6. PubMed ID: 8438491
[No Abstract] [Full Text] [Related]
8. Case 6: benefits and risks of OKT3 treatment in renal transplantation.
First MR
Transplantation; 2001 Sep; 72(6):1177-8. PubMed ID: 11584824
[No Abstract] [Full Text] [Related]
9. OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A.
Widmer U; Frei D; Keusch G; Burger HR; Largiader F; Binswanger U
Transplant Proc; 1988 Oct; 20(5 Suppl 6):90-5. PubMed ID: 3140454
[No Abstract] [Full Text] [Related]
10. Selection criteria for antirejection therapy.
Wilmink JM
Transplant Proc; 1990 Dec; 22(6):2601-3; discussion 2603-4. PubMed ID: 2124742
[No Abstract] [Full Text] [Related]
11. Use of Orthoclone OKT3 as treatment of acute renal allograft rejection and as first-line therapy in kidney transplantation.
Winde G; Dietl KH; Raidt H; Buchholz B; Lison AE; Bünte H
Transplant Proc; 1988 Oct; 20(5 Suppl 6):87-9. PubMed ID: 3140453
[No Abstract] [Full Text] [Related]
12. Immunosuppressive drugs for kidney transplantation.
Halloran PF
N Engl J Med; 2004 Dec; 351(26):2715-29. PubMed ID: 15616206
[No Abstract] [Full Text] [Related]
13. Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.
Monaco A; Goldstein G; Barnes L
Transplant Proc; 1987 Apr; 19(2 Suppl 1):28-31. PubMed ID: 3105137
[No Abstract] [Full Text] [Related]
14. Comparison of T10Bg.1A-31 and OKT3 in treating acute renal allograft rejection.
Lucas BA; Waid TH; Thompson JS; Brown SA; Munch LC; McKeown JW; Kryscio RJ; Prebeck RJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):543-5. PubMed ID: 8438406
[No Abstract] [Full Text] [Related]
15. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation.
McVicar JP; Kowdley KV; Emond MJ; Barr D; Marsh CL; Carithers RL; Perkins JD
Clin Transplant; 1997 Aug; 11(4):328-33. PubMed ID: 9267724
[TBL] [Abstract][Full Text] [Related]
16. OKT3 monoclonal antibody reversal of acute renal allograft rejection unresponsive to conventional immunosuppressive treatments.
Goldstein G; Norman DJ; Shield CF; Kreis H; Burdick J; Flye MW; Rivolta E; Starzl T; Monaco A
Prog Clin Biol Res; 1986; 224():239-49. PubMed ID: 3540993
[No Abstract] [Full Text] [Related]
17. Use of monoclonal antibodies to T cells (OKT3) for treatment of acute cellular rejection after renal transplantation.
Birkeland SA; Svendsen V; Rohr N; Hansen BL; Elbirk A; Foged N; Køhler F
Transplant Proc; 1988 Jun; 20(3):451-4. PubMed ID: 3289183
[No Abstract] [Full Text] [Related]
18. Proliferation rate of cells in the interstitial infiltrate in acute kidney allograft rejection.
Olsen S; Hansen HE
Transplant Proc; 1996 Feb; 28(1):502-3. PubMed ID: 8644329
[No Abstract] [Full Text] [Related]
19. Use of antilymphocyte induction therapy in liver transplantation: A European perspective.
Langrehr JM; Neuhaus PJ
Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S71-84. PubMed ID: 10431020
[No Abstract] [Full Text] [Related]
20. Biological immunosuppressants: the way to clinical transplantation tolerance.
Chatenoud L
Transplant Proc; 1997; 29(1-2):51-5. PubMed ID: 9123108
[No Abstract] [Full Text] [Related]
[Next] [New Search]
